nelfinavir has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, WA; Fousek, K; Guan, M | 1 |
| Adachi, Y; Ikezoe, T; Koeffler, HP; Ohtsuki, Y; Taguchi, H; Takeuchi, S; Takeuchi, T; Yang, Y | 1 |
2 other study(ies) available for nelfinavir and Cancer of Prostate
| Article | Year |
|---|---|
Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer.
Topics: Activating Transcription Factor 6; Apoptosis; Autophagy; Blotting, Western; Caspases; Castration; Cell Nucleus; Cell Proliferation; Endoplasmic Reticulum Stress; Fatty Acid Synthase, Type I; Green Fluorescent Proteins; HIV Protease Inhibitors; Humans; Immunoenzyme Techniques; Male; Metalloendopeptidases; Nelfinavir; Proprotein Convertases; Prostatic Neoplasms; Protein Transport; Proteolysis; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Serine Endopeptidases; Sterol Regulatory Element Binding Protein 1; Transcription, Genetic; Tumor Cells, Cultured | 2012 |
HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling.
Topics: Animals; Apoptosis; Cell Line, Tumor; DNA-Binding Proteins; Down-Regulation; HIV Protease Inhibitors; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Nelfinavir; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Signal Transduction; STAT3 Transcription Factor; Trans-Activators | 2005 |